INFORMED.
LIVE

Syngene International Limited

BSE: SYNGENE539268ISIN INE398R01022
  • Healthcare
  • Healthcare Research, Analytics & Technology
  • BSE 500

Share price

₹369.25-10.70 (-2.82%)
as of 18 Sep 2026
Syngene International Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹658.35 to ₹369.25 (-43.9%). Low ₹369.25, high ₹663.65. Volume shown below the price.
52W high
₹678.00
52W low
₹366.80
Off 52W high
-45.54%
1M return
-7.01%
3M return
-16.25%
6M return
-10.95%
1Y return
-43.91%
20D avg volume
29,609
50 DMA
₹402.04
200 DMA
₹468.66

Key ratios Consolidated

Market cap
₹14,905 Cr
Current price
₹369.25
52W high / low
₹678.00 / ₹366.80
Face value
₹10.00
P/E
67.45
P/B
EPS (TTM)
₹5.47
Book value / share
ROE
ROCE
8.40%
Operating margin
Net margin
Debt / equity
0.00
Net debt
₹-219.20 Cr
Interest cover
9.42
Dividend yield
0.34%
Dividend / share (TTM)
₹1.25
Payout
22.85%
Cash conversion cycle
29.6 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24
Income statement
736.001,036917.10910.60874.501,018943.70891.00789.70916.90853.50910.10
25.3022.2015.4015.4017.7018.9018.3016.5018.1016.1029.3021.60
767.00856.70833.50840.80790.90796.40781.20770.20738.50724.00740.90773.60
178.20223.30220.90227.50239.50228.10241.90230.80168.00172.10240.30241.80
0.000.000.000.000.000.00
259.10300.80267.40275.00261.70253.00249.50251.50229.90226.90220.90225.50
9.6012.1011.9013.2011.6015.9012.4013.1011.7012.9010.8013.00
112.20111.50113.70116.50111.20106.10108.70110.90106.90111.10108.10104.60
212.70199.20211.10197.60188.80186.40174.90162.40153.20160.30151.30145.40
-5.70202.0099.0085.20101.30240.50180.80137.3069.30209.00141.90158.10
-13.50-6.00-70.600.000.000.000.000.0032.000.00-3.70-7.40
-19.20196.0028.4085.20101.30240.50180.80137.30101.30209.00138.20150.70
-10.2048.1013.4018.1014.6057.2049.7031.2025.6020.4026.7034.20
-9.00147.9015.0067.1086.70183.30131.10106.1075.70188.60111.50116.50
-0.223.680.371.672.164.563.272.641.894.702.782.90
Key metrics
102.60319.60154.00214.90224.10362.50301.90261.30219.90333.00257.10268.30
13.90%30.80%16.80%23.60%25.60%35.60%32.00%29.30%27.80%36.30%30.10%29.50%
-1.20%14.30%1.60%7.40%9.90%18.00%13.90%11.90%9.60%20.60%13.10%12.80%
3.80%1.80%4.70%
-15.80%1.80%-2.80%2.20%10.70%11.00%10.60%-2.10%
-110.40%-19.30%-88.60%-36.80%14.50%-2.80%17.60%-8.90%
MetricTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18
Income statement
3,6003,7393,6423,4893,1932,6042,1842,0121,8261,423
78.3070.7071.8090.6070.9052.8064.6081.6075.1061.80
3,2983,3223,0862,9472,6702,1421,8151,6481,4851,112
849.90911.20925.40873.60902.20770.60551.70518.60505.30
0.000.000.00
1,1021,105983.90888.70841.70718.10660.20580.40472.70379.60
46.8048.8053.1047.2045.2024.1027.7034.6032.3022.70
453.90452.90432.60425.90366.50309.70274.50219.30164.20
820.60796.70674.20599.50514.80395.80342.90308.60282.90270.90
380.50487.50627.90631.90593.60515.10434.20445.60415.40372.50
-90.10-76.6032.00-11.100.00-30.7035.0071.300.000.00
290.40410.90659.90620.80593.60484.40469.20516.90415.40372.50
69.4094.20163.70110.80129.2088.6064.30104.8083.8067.10
221.00316.70496.20510.00464.40395.80404.90412.10331.60305.40
5.507.8712.3512.7111.599.9410.1810.3816.77
Key metrics
791.10912.601,1461,0941,005818.20771.40770.80611.90395.20
21.97%24.40%31.50%31.40%31.50%31.40%35.30%38.30%33.50%27.80%
6.14%8.50%13.60%14.60%14.50%15.20%18.50%20.50%18.20%21.50%
8.40%13.20%
2.60%4.40%9.30%22.60%19.20%8.60%10.20%28.30%
-36.20%-2.70%9.80%17.30%-2.20%-1.70%24.30%8.60%
571.20407.30
2.892.35
0.000.03
-219.20-247.50
29.633.1
Balance sheet
7,0556,796
2,1432,287
228.60367.10
508.80526.70
141.30155.50
166.30130.00
2,5452,323
347.50352.00
1,5521,396
9.40119.60
9.40119.60
0.000.00
4,8394,727
Cash flow
915.201,168
-860.40-744.70
-215.00-141.80
344.00760.30
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24
Income statement
663.00960.00834.40830.10799.30948.40877.10821.30726.50864.70791.90830.70
24.8021.6014.5014.2016.6018.4018.0016.4017.7015.3028.8021.00
684.30777.50753.00760.10731.70738.10725.30713.40677.40669.60692.30713.60
158.50202.20197.90201.20223.00212.80229.10216.20210.20162.40227.60235.30
0.000.000.000.000.000.00
207.00248.50217.50225.90212.60209.40212.60224.10195.60195.10196.50190.60
4.106.506.207.405.9010.106.707.007.408.506.308.60
95.6095.3097.10100.1094.6089.6092.3093.7091.7095.7093.6090.90
223.90215.20225.80214.50217.50209.20190.30170.60160.80167.20158.70144.10
3.50204.1095.9084.2084.20228.70169.80124.3066.80210.40128.40138.10
-13.50-7.40-65.800.000.000.0032.00-3.70-7.40
-10.00196.7030.1084.2084.20228.70169.80124.3098.80210.40124.70130.70
-7.9048.5013.6018.0010.2054.3046.7027.7024.9020.6024.9029.10
-2.10148.2016.5066.2074.00174.40123.1096.6073.90189.8099.80101.60
-0.053.680.411.651.844.343.072.411.844.732.492.53
Key metrics
89.70298.50133.40191.70184.70328.40268.80225.00197.90314.60224.60230.20
13.50%31.10%16.00%23.10%23.10%34.60%30.60%27.40%27.20%36.40%28.40%27.70%
-0.30%15.40%2.00%8.00%9.30%18.40%14.00%11.80%10.20%21.90%12.60%12.20%
4.00%1.80%4.70%
-17.10%1.20%-4.90%1.10%10.00%9.70%10.80%-1.10%
-102.80%-15.00%-86.60%-31.50%0.10%-8.10%23.30%-4.90%
MetricTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18
Income statement
3,2883,4243,3733,2033,1942,6012,1792,0121,8261,423
75.1066.9070.5088.0070.9052.8064.6081.6075.1061.80
2,9753,0222,8542,7232,6642,1421,8121,6491,4861,113
759.80824.30868.30839.10902.20770.60551.70518.60505.30
0.000.000.00
898.90904.50841.70761.20812.20697.80641.50572.20465.40376.90
24.2026.0031.2029.5045.2024.1027.7034.6032.3022.70
388.10387.10367.30368.90359.10309.70274.50219.30164.20131.40
879.40873.00728.60611.20545.00416.00358.50318.00274.00
387.70468.40589.60568.40600.90512.40432.40444.40414.20372.10
-86.70-73.2032.00-11.10-30.7035.0071.30
301.00395.20621.60557.30600.90481.70467.40515.70414.20372.10
72.2090.30153.6090.80127.9087.9063.70104.2083.5067.00
228.80304.90468.00466.50473.00393.80403.70411.50330.70305.10
5.697.5811.6411.6211.819.8910.1510.3616.72
Key metrics
713.30808.301,020955.701,005815.50769.60769.60610.70526.20
21.70%23.60%30.20%29.80%31.50%31.30%35.30%38.30%33.50%37.00%
6.96%8.90%13.90%14.60%14.80%15.10%18.50%20.50%18.10%21.40%
8.20%12.90%
1.50%5.30%0.30%22.80%19.40%8.30%10.20%28.30%
-34.90%0.30%-1.40%20.10%-2.50%-1.90%24.40%8.40%
567.20744.50
2.732.38
0.000.02
-120.50-131.00
27.729.6
Balance sheet
6,5636,407
1,8762,034
120.50233.50
432.50469.40
136.90150.30
101.0071.20
2,2441,994
310.00346.50
1,4191,329
0.00102.50
0.00102.50
0.000.00
4,7044,639
Cash flow
831.001,114
-783.80-810.40
-177.80-136.50
263.80369.30

Compounded growth

Standalone

Sales CAGR 3Y
+2.35%
Sales CAGR 5Y
+9.45%
Sales CAGR 10Y
Profit CAGR 3Y
-13.62%
Profit CAGR 5Y
-5.46%
Profit CAGR 10Y
Sales YoY (TTM)
-4.60%
Profit YoY (TTM)
-51.12%

Consolidated

Sales CAGR 3Y
+5.40%
Sales CAGR 5Y
+11.35%
Sales CAGR 10Y
Profit CAGR 3Y
-11.98%
Profit CAGR 5Y
-4.79%
Profit CAGR 10Y
Sales YoY (TTM)
-3.41%
Profit YoY (TTM)
-56.43%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
52.59%
HolderTypeHoldingPreviousChange
BIOCON LIMITEDPromoter52.32%
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA FOPublic7.73%
ICICI PRUDENTIAL NIFTY SMALLCAP 250 ETFPublic5.30%
DSP NIFTY SMALLCAP 250 INDEX FUNDPublic4.61%
GOVERNMENT OF SINGAPOREPublic2.13%
SBI NIFTY SMALLCAP 250 INDEX FUNDPublic1.95%
MIRAE ASSET NIFTY 500 HEALTHCARE ETFPublic1.85%
LIFE INSURANCE CORPORATION OF INDIAPublic1.78%
HSBC MUTUAL FUND - HSBC MIDCAP FUNDPublic1.55%
BIOCON LIMITED EMPLOYEE WELFARE TRUST (MURALI KRISHNAN K N and K NANDA KUMAR)Promoter Group0.26%
KIRAN MAZUMDAR SHAWPromoter Group0.01%
DEV MAZUMDARPromoter Group0.00%
BIOCON RESEARCH LIMITEDPromoter Group0.00%
RAVI RASENDRA MAZUMDARPromoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 1.250025 Jun 202626 Jun 2026
Final Dividend - Rs. - 1.250027 Jun 202527 Jun 2025
Final Dividend - Rs. - 1.250028 Jun 202428 Jun 2024

Board meetings

  • Board Meeting - Financial Results